PDSB earnings: a positive outcome, +26.1%

On November 14, 2022, PDS Biotechnology Corp reached its earnings. The result was a positive outcome, and the stock moved +26.1% in the window around the event. It had already run +40.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.